Shingles Vaccine Market Regional Analysis:
North America and Europe are expected to collectively account for a major share of the market
between 2016 and 2024. North America market growth is primarily driven by rising demand in
the U.S., while the market in Europe is expected to be driven by increased therapeutic demand
from European Union.
Asia Pacific shingles vaccine market is expected to witness highest growth over the forecast
period. There is a wide addressable market that needs to be capitalized upon in the region
especially in China and India. Active marketing and differential pricing would help companies
to strengthen their market presence in Asia Pacific.
Shingles Vaccine Market Opportunity:
Prevalence of shingles is increasing across the globe, fuelled mainly by increasing aging
population. However, high cost of vaccines is limiting vaccination drive in emerging economies,
characterized by inadequate insurance coverage. The major concern among healthcare experts is
reduction in postherpetic neuralgia from the shingles vaccine. Zostavax has been successful to a
certain extent in reducing postherpetic neuralgia due to the effect of the vaccine on reducing
risk of developing herpes zoster. Better outcomes of Shingrix would be a boon for highly
lucrative global shingles vaccines market.
Request For Customization of Research Report @ https://bit.ly/2U7ntjz
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com